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ABSTRACT
Objectives: To investigate if there is evidence on
effectiveness of progressive resistance training in
rehabilitation of Parkinson disease.
Design: Systematic review and meta-analysis. Data
sources: Central, Medline, Embase, Cinahl, Web of
Science, Pedro until May 2014. Randomised controlled
or controlled clinical trials. The methodological quality
of studies was assessed according to the Cochrane
Collaboration’s domain-based evaluation framework.
Data synthesis: random effects meta-analysis with test
for heterogeneity using the I² and pooled estimate as
the raw mean difference.
Participants: Adults with primary/idiopathic
Parkinson’s disease of any severity, excluding other
concurrent neurological condition.
Interventions: Progressive resistance training defined
as training consisting of a small number of repetitions
until fatigue, allowing sufficient rest between exercises
for recovery, and increasing the resistance as the ability
to generate force improves.
Comparison: Progressive resistance training versus
no treatment, placebo or other treatment in randomised
controlled or controlled clinical trials.
Primary and secondary outcome measures: Any
outcome.
Results: Of 516 records, 12 were considered relevant.
Nine of them had low risk of bias. All studies were
randomised controlled trials conducted on small
samples with none or 1 month follow-up after the end
of intervention. Of them, six were included in
quantitative analysis. Pooled effect sizes of meta-
analyses on fast and comfortable walking speed, the
6 min walking test, Timed Up and Go test and maximal
oxygen consumption were below the level of minimal
clinical significance.
Conclusions: There is so far no evidence on the
superiority of progressive resistance training compared
with other physical training to support the use of this
technique in rehabilitation of Parkinson’s disease.
Systematic review registration number:
PROSPERO 2014:CRD42014009844.
INTRODUCTION
Principles of progressive resistance training
(PRT) have remained essentially unchanged
since 1945–1949, when US Army physician
Captain Thomas L. Delorme introduced this
technique as an efﬁcient way to rehabilitate
soldiers.1 2 For 70 years, PRT has been widely
used in rehabilitation of young and physically
active people. During the past two decades,
use of PRT has also been studied among
people with chronic diseases and disabil-
ities3 4 such as hypertension, chronic
obstructive pulmonary disorders, chronic low
back and neck pain, osteoarthritis, cerebral
palsy, stroke and diabetes. In these condi-
tions, PRT may reduce pain, and improve
muscle strength and the level of physical
activity without signiﬁcant side effects.3
The data on the effectiveness of PRT in
the rehabilitation of people with Parkinson’s
disease are scarce. The conclusions of recent
reviews on the topic show inconsistency of
inferences. In a recent systematic review by
Brienesse et al5 of ﬁve randomised controlled
trials (RCT), PRT was found to have a posi-
tive effect on muscle strength, mobility,
endurance, fat-free mass and performance in
functional tasks. Another recent systematic
review by Lima et al6 of four controlled trials
suggested that PRT could be effective in
increasing walking capacity in Parkinson’s
disease. A narrative review by David et al7
reported a favourable effect of PRT on
muscle strength and function and non-motor
symptoms of Parkinson’s disease. Also, a nar-
rative review by Falvo et al8 emphasised the
lack of robust data on the topic. While Lima
et al and David et al ended up with a strong
Strengths and limitations of this study
▪ Search in six major databases.
▪ More relevant studies identified compared to pre-
vious meta-analyses.
▪ Reviewing process followed recommendations
by Cochrane Collaboration.
▪ Owing to the uncertain definition of progressive
resistance training, it is possible that some rele-
vant studies remained undetected.
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conclusion that there is evidence that progressive resist-
ance training should be implemented in Parkinson’s
disease rehabilitation, the conclusions of Brienesse et al
and Falvo et al indicated more cautiously that data are
insufﬁcient to make robust recommendations and
further research is needed.
The purpose of this study was to evaluate the evidence
on the effectiveness of PRT in the rehabilitation of
people with Parkinson’s disease, and to make concrete
recommendations for clinical practice.
METHODS
Data sources and searches
Criteria for considering studies for this review were
based on the PICO (Population, Intervention,
Comparison, and Outcome) framework as follows:
▸ Patients: Adults with primary/idiopathic Parkinson’s
disease of any severity, excluding any other concur-
rent neurological condition.
▸ Intervention: Progressive resistance training deﬁned
as training which (A) consists of a small number of
repetitions until fatigue, (B) allows sufﬁcient rest
between exercises for recovery and (C) increases the
resistance as patient’s ability to generate force
improves.3
▸ Comparison: Progressive resistance training versus no
treatment, placebo or other treatment in randomised
controlled or controlled clinical trials.
▸ Outcome: Any outcome.
Cochrane Controlled Trials Register (CENTRAL),
MEDLINE (via PubMed), EMBASE, CINAHL, Web of
Science and Physiotherapy Evidence (Pedro) databases
were searched in May 2014 with no restrictions by date
or language. The search clauses are presented in online
supplementary ﬁle 1. In order to avoid missing relevant
studies, the use of limits was restricted and further selec-
tion was conducted manually. The references of identi-
ﬁed articles and reviews were also checked for relevancy.
Study selection
Two independent reviewers (EB and MS) screened the
titles and abstracts of articles, assessed the full texts of
potentially relevant studies, and rated the methodo-
logical quality of included trials (ﬁgure 1).
Disagreements between reviewers were resolved by
consensus or by the third reviewer ( JP). The more
detailed description of the exclusion process is available
on request from the corresponding author.
Data extraction and quality assessment
Data needed for meta-analysis were extracted from the
included trials using a standardised form based on
Figure 1 Flow chart of reviewing process.
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recommendations by the Cochrane Handbook for
Systematic Reviews of Interventions V.5.1.0, part 7.6.9 If a
study was reported in more than one publication, the
information from multiple reports was collated by
extracting data from each report separately and then
combining the information of all data collection forms.
The methodological quality was assessed according to
the Cochrane Collaboration’s domain-based evaluation
framework.10 Main domains were assessed in the follow-
ing sequence: (1) selection bias (randomised sequence
generation and allocation concealment); (2) perform-
ance bias (blinding of participants and personnel); (3)
detection bias (blinding of outcome assessment); (4)
attrition bias (incomplete outcome data, eg, due to
dropouts); (5) reporting bias (selective reporting); (6)
other sources of bias. The scores for each bias domain
and the ﬁnal score of risk of systematic bias were graded
as low, high or unclear risk.
Data synthesis and analysis
We used a random effects meta-analysis to quantify the
pooled effect size of included studies as a more natural
choice than ﬁxed effects in the context of multiple clin-
ical trials conducted in diverse settings. In addition, test
for heterogeneity supported this choice. The test for het-
erogeneity was conducted using the I2 statistic describing
the percentage of variation across studies originating
more from heterogeneity than from chance. We calcu-
lated the non-standardised means of difference in
change of means for each study and for the pooled
study sample. When the SD of difference of changes of
groups’ means was not reported, the coefﬁcient of cor-
relation between prevariance and postvariance was set at
0.6. The potential publication bias was evaluated by
Egger’s test for asymmetry of the funnel plot (test for
the Y intercept=0 from the linear regression of normal-
ised effect estimate against precision), where the
trim-and-ﬁll method was used to impute studies into a
funnel plot to correct asymmetry. All calculations for the
meta-analysis were performed using MIX 2.0. V.2.0.1.4.
BiostatXL, 2011, available from http://www.
meta-analysis-made-easy.com, Comprehensive Meta
Analysis CMA, V.2.2.064, available from http://www.
meta-analysis.com, and Microsoft Excel 2013.
RESULTS
The search resulted in 516 records. Of them, 297 study
reports were removed as being duplicates, conference
proceedings, posters, theses, etc. After including ﬁve
reports found from the reference lists of identiﬁed
review articles, 224 records were screened on the basis
of their titles and abstracts. Of these records, full texts of
58 reports were screened more thoroughly, and 12 were
considered relevant for qualitative analysis11–22 (details
in ﬁgure 1). Similarity of outcome measures, needed for
meta-analysis, was found among ﬁve different
reports.11 14 20–22 Additionally, two subgroups in the
study by DiFrancisco-Donoghue et al17 (one sample com-
paring PRT with usual care and another comparing PRT
and vitamins with vitamins alone) were used in
meta-analysis.
Qualitative analysis of 12 included studies
Table 1 shows the descriptive characteristics of included
studies. Publication years varied from 1997 to 2014.
Eight studies were conducted in the USA and four in
Australia. The size of the intervention groups at the end
of follow-up varied from 6 to 22. Most of the studies only
reported pretreatment/post-treatment results. Two of 12
studies also had a short 1 month follow-up after inter-
vention.13 19 In the samples, male gender predominated
and the mean age of participants varied from 59 to
71 years. The implementation schemes of PRT varied
widely across the studies. The progression of training
load was usually deﬁned by one repetition maximum, by
participant’s fatigue, or by achieving an agreed amount
of repetitions. The duration of intervention varied from
1.5 to 24 months with a frequency of two or three times
per week. Of 12 studies, 10 reported a positive effect of
intervention. Six studies compared progressive resistance
training with weakly deﬁned ‘usual activities’,11–13 16–18
four with different low-intensity strengthening, endur-
ance or balance exercises,14 15 19 20 one with the use of
vitamins,17 and one with treadmill training.22 It is self-
evident that most of the patients with PD have more
than one treatment. Thus, when comparing PRT and
vitamins against only vitamins, omitting vitamins was
accepted by us as approximation and the study by
DiFrancisco-Donoghue et al17 could be included into
this review. The outcome measures of included studies
spread across a wide spectrum and are presented in
online supplementary ﬁle 2 along with their reported
main results.
The risk of bias was considered low for nine studies
and high for three studies (table 2). The most frequent
source of potential bias was the performance bias
related to the inadequate or insufﬁciently reported
blinding procedure.
The included studies reported positive effects of PRT
on the score of the Freezing of Gait Questionnaire,11
oxidative stress,12 gait velocity and endurance,14 the
scores of Parkinson’s Disease Rating Scale and Modiﬁed
Fitness Counts,15 cognitive functioning (demonstrating
no effect on mood or disease-speciﬁc quality of life),16
gait initiation performance18 and muscle strength of
trunk and/or lower extremities.13 19–22 One study found
PRT to be more effective at increasing glutathione levels
and decreasing homocysteine levels compared with con-
trols but without differences when compared with
vitamin intake.17
Meta-analyses of six included studies
The risk of bias of all six studies was considered low. Five
different meta-analyses were conducted on two to four
samples sized from 6 to 22 participants each. When
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Table 1 Descriptive characteristics of included studies
Study/year/country
Cases/controls,
N (% men) Intensity and
duration
Response to
treatmentBaseline Follow-up Age * Case treatment Control treatment
Allen
2010
Australia
24 (54)/24
(54)
21/24 66/68 Progressive lower limb strengthening and
balance exercises (a monthly exercise
class, remaining exercise sessions at
home). Standardised falls prevention
advice (booklet)
40–60 min 3
times per week
for 6 months
Usual care. Standardised
falls prevention advice
(booklet)
Insignificant
difference
Bloomer
2008
USA
8 (50)/8
(50)
6/7 61/57 Three sets of 5–8 repetitions: leg press, leg
curl and calf press. Increased weight by 5–
10% when 8 repetitions were completed for
all 3 sets
Two times per
week for
2 months
Usual activity Positive
Bridgewater
1997
Australia
13 (69)/13
(54)
13/13 67/66 15 min warm-up. Trunk muscles (back
extensors and abdominals): 10 repetitions
of 7 s isometric contractions with 7 s rest.
Progression: as individual ability and
improvement allowed
Two times per
week for
3 months
Usual activity and ‘interest
talks’ on health issues
Once every 3 weeks
Positive
Combs
2013
USA
17 (65)/14
(71)
11/11 67/68 15 min warm-up. Boxing circuit, endurance.
Progression: self-progressed by completing
more repetitions during each training bout
as intensely as tolerated
24–36×90 min
for 3 months
Strengthening, endurance
and balance exercises
Positive
Corcos
2013
USA
24 (58)/24
(58)
20/18 59/59 Strength: 1–3 sets of 8×6–9 s repetitions;
speed: 2 sets of 12 repetitions.
Progression: 5% depending on one
repetition maximum
Two times per
week for
24 months
Stretches, balance
exercises, breathing and
non-progressive
strengthening
Positive
Cruise
2011
Australia
15 (60)/13
(69)
14/10 59/61 5 min warm-up (walking, stationary cycling
and stretching), 6 resistance exercises.
Progression: 5–10% based on one
repetition maximum. Aerobic component
25–30 min
60 min 2 times
per week for
3 months
Usual activities Positive
DiFrancisco-Donoghue
2012
USA
10 (77)/9
(33) †
12 (56)/10
(56)‡
9/9†
9 9‡
68/
68†
67/
69‡
20 min aerobic exercise, weight training 2
sets of 8–15 repetitions with 30 s rest
between. Progression: weight increased by
5 lbs when 15 repetitions per set were
achieved
40 min 2 times
per week for 1½
months
Usual activities.
Vitamins: folic acid, B12 and
B6
Insignificant
difference
Hass
2012
USA
9 (77)/9
(77)
9/9 64/67 5 min warm-up, 2 sets of 12–20 repetitions
of six exercises, 5 min break between sets.
Progression based on one repetition
maximum
Two times per
week for 2½
months
Usual activities Positive
Hirsch
2003
USA
6/9 6/7§
6/9¶
71/76 Balance+resistance training. Resistance
training: 15 min lower extremities, 1 set of
12 repetitions, and 2 min rest between
Three times per
week for 2½
months
Balance training Positive
Continued
4
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Table 1 Continued
Study/year/country
Cases/controls,
N (% men) Intensity and
duration
Response to
treatmentBaseline Follow-up Age * Case treatment Control treatment
exercises. Progression based on 4
repetitions maximum
Paul
2014
Australia
20 (65)/20
(60)
18/18§ 19/
19**
68/65 Three sets of 8 repetitions for 4 muscle
groups. Progression: increase by 5% when
10 repetitions achieved
45 min 2 times
per week for
3 months
Low intensity exercises for
the trunk, leg flexors, leg
extensors and hip
abductors
Positive
Schilling
2010
USA
9/9 8 (63)/7
(57)
61/57 Warm-up, 3 sets of 5–8 repetitions of the
leg press, leg curl and calf press.
Progression: when 8 repetitions for all 3
sets were completed, the weight was
increased by 5–10%
Two times per
week for
2 months
Standard care Positive
Shulman
2013
USA
28††/
26‡‡
22 (82)††/
22(73)‡‡
65††/
66‡‡
Resistance exercises: 2 sets of 10
repetitions (leg press, leg extension and leg
curl). Progression: weight increased as
tolerated
Three times per
week for
3 months
50 min of lower intensity
treadmill
Positive on
muscle
strength
*Years in means.
†Training versus controls.
‡Training and vitamins versus vitamins.
§Strength.
¶Balance.
**Mobility and balance.
††Stretching and Resistance Training.
‡‡Lower-Intensity treadmill training (higher-intensity treadmill excluded as progressive training of different type).
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appropriate, measurement units were converted into
metric units. Table 3 and online supplementary
ﬁgures 3A–E present the input data and the results of all
ﬁve syntheses.
The effect of PRT on fast walking speed was assessed
by pooling samples of three studies.11 20 22 The pooled
sample consisted of 49 cases versus 55 controls. The
pooled effect size was 0.06 ms (95% CI 0.02 to 0.11) in
favour of intervention, but below the minimal detectable
change of 0.25 ms as suggested previously.23 The I2 was
61%, indicating substantial heterogeneity.
The effect of PRT on comfortable walking speed was
assessed by pooling samples of four studies.11 14 20 22
The pooled sample consisted of 60 cases versus 66 con-
trols. The pooled effect size was 0.03 ms (95% CI 0.01 to
0.05) in favour of intervention, but below the minimal
detectable change of 0.18 ms as suggested previously.23
The I2 was 15%, indicating insigniﬁcant heterogeneity.
The effect of PRT on Timed Up and Go test was
assessed by pooling samples of three studies.14 20 21 The
size of pooled sample was 26 cases versus 29 controls.
The pooled effect size was statistically insigniﬁcant
−0.71 s (95% CI −1.47 to 0.06) in favour of intervention
and below the minimal detectable change of 3.5 s as sug-
gested previously.24 The I2 was 0%, indicating insigniﬁ-
cant heterogeneity.
The effect of PRT on the 6 min walk test was assessed
by pooling samples of three studies.14 21 22 The pooled
sample was 42 cases versus 42 controls. The pooled
effect size was 16.67 m (95% CI 7.86 to 25.48) in favour
of intervention, but below the minimal detectable
change of 82 m as suggested previously.23 The I2 was
47%, indicating moderate heterogeneity.
The effect of PRT on maximal oxygen consumption
was assessed by pooling samples of two studies17 22
including three samples: two different samples from the
study by DiFrancisco-Donoghue et al and one sample
from the study by Shulman et al. The pooled sample was
40 cases versus 40 controls. The pooled effect size was
−1.6 mL/kg/min (95% CI −1.93 to −1.27) in favour of
intervention and below the minimal clinically signiﬁcant
difference of 2 mL/kg/min as suggested previously.25
The I2 was 85%, indicating substantial heterogeneity.
The Egger’s test for asymmetry of the funnel plot did
not reveal a potential publication bias in any of the
syntheses.
DISCUSSION
In this systematic review of 12 RCTs, no evidence was
found on the superiority of PRT in the rehabilitation of
people with idiopathic Parkinson’s disease when com-
pared to other training or to usual activities. Few studies
conducted on small sample sizes with short periods of
follow-up reported some positive effects of PRT on freez-
ing symptoms, gait, cognitive performance and muscle
strength. Meta-analyses of these studies did not ﬁnd clin-
ically signiﬁcant effects of PRT on walking speed,
walking distance, Timed Up and Go test or aerobic
performance.
The case and control treatments, as well as intensity,
duration and frequency of PRT, employed in the
selected studies were diverse and sometimes hardly com-
parable. The included studies have been conducted on
relatively small samples and the effects were followed up
for only a few months at most. In this review, a ‘small
number of repetitions’ was deﬁned according to the
classic work of DeLorme and Watkins in 1948.2 The use
of a more precise deﬁnition given by the American
College of Sports Medicine, deﬁning a ‘small number of
repetitions’ as ≤12 repetitions, might alter our results.26
Owing to the uncertain deﬁnition of PRT, it is possible
that some relevant studies remained undetected.
However, we used very wide search clauses and per-
formed the rest of the search and selection manually in
order to avoid missing the potentially relevant reports.
Table 2 Risk of bias of included studies
Study
Random
sequence
generation
Allocation
concealment
Blinding of
participants
and
personnel
Blinding of
outcome
assessment
Incomplete
outcome
data
Selective
reporting
Other
sources
of bias
Total
risk
of
bias
Allen et al11 Low Low High Low Low Low Low Low
Bloomer et al12 Low Unclear High Low Low Low Low Low
Bridgewater et al13 High Unclear High High Low Low Low High
Combs et al14 Low Low High Low Low Low Low Low
Corcos et al15 Low Low High Low Low Low Low Low
Cruise et al16 High Unclear High High Low Low Low High
DiFrancisco-Donoghue
et al17
Low Unclear High High Low Low Low Low
Hass et al18 Low Unclear High High Low Low Low Low
Hirsch et al19 High Unclear High High Low Low Low High
Paul et al20 Low Unclear High Low Low Low Low Low
Schilling et al21 Low Unclear High High Low Low Low Low
Shulman et al22 Low Low Low Low Low Low Low Low
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Table 3 Results of meta-analyses
Outcome (units), study
Cases, mean (SD) Controls, mean (SD) Effect size
I2 (%)
Egger’s regression
Baseline Follow-up N Baseline Follow-up N
Raw mean
difference 95% CI Intercept 95% CI
Fast walking speed (ms) 0.06 0.02 to 0.11 61 −3.27 −69.0 to 62.4
Allen et al11 1.47 (0.38) 1.61 (0.35) 21 1.54 (0.35) 1.48 (0.43) 24 0.2 −0.001 to 0.40
Paul et al20 – 0.02 (0.16)* 6 – 0.01 (0.19)* 9 0.01 −0.18 to 0.2
Shulman et al22† 0.84 (0.05) 0.84 (0.05) 22 0.85 (0.05) 0.79 (0.05) 22 0.06 0.03 to 0.09
Comfortable walking speed (ms) 0.03 0.01 to 0.05 15 −1.34 −13.8 to 11.2
Allen et al11 1.07 (0.27) 1.09 (0.26) 21 1.04 (0.25) 1.06 (0.32) 24 0.0 −0.15 to 0.15
Combs et al14 1.06 (1.08) 1.10 (1.10) 11 1.15 (0.72) 1.22 (0.64) 11 0.03 −0.65 to 0.71
Paul et al20 – 0.06 (0.16)* 6 – 0.05 (0.12)* 9 0.01 −0.13 to 0.15
Shulman et al22‡ 0.72 (0.05) 0.71 (0.05) 22 0.73 (0.04) 0.69 (0.04) 22 0.03 0.01 to 0.05
Timed Up and Go Test (s) −0.71 −1.47 to 0.06 0 −5.28 −61.1 to 50.5
Combs et al14 8.05 (15.12) 7.12 (14.62) 11 7.64 (7.39) 7.12 (5.47) 11 −0.41 −9.04 to 8.22
Paul et al20 – −1.3 (2.7)* 6 – −0.1 (2.0)* 9 −1.2 −3.57 to 1.17
Schilling et al21 5.8 (0.50) 5.7 (0.80) 9 7.5 (1.18) 6.75 (1.21) 9 −0.65 −0.47 to 0.06
6 min walk (m) 16.67 7.86 to 25.48 47 −6.14 −42.8 to 30.5
Combs et al14 405.0
(549.1)
457.0 (669.7) 11 484.4
(301.2)
478.7 (183.9) 11 57.7 −300.21 to 415.6
Schilling et al21 537.7 (88.1) 586.9 (51.0) 9 468.8 (83.3) 493.9 (64.3) 9 24.1 −39.97 to 88.17
Shulman et al22§ – 32.6 (14.6)* 22 – 49.1 (15.5)* 22 16.5 7.86 to 25.48
Maximal oxygen consumption (mL/kg/min) −1.6 −1.93 to −1.27 85 26.18 −103.5 to 155.9
DiFrancisco-Donoghue
et al17¶
13.3 (2.7) 11.6 (2.4) 9 13.0 (2.8) 12.8 (2.9) 9 −1.5 −3.74 to 0.74
DiFrancisco-Donoghue
et al17**
11.5 (2.1) 10.0 (2.0) 9 13.9 (2.8) 14.6 (2.6) 9 −2.2 −4.19 to −0.22
Shulman et al22 – −0.052 (0.4) * 22 – 1.53 (0.7)* 22 −1.6 −1.93 to −1.25
*Change from baseline for each group.
†Converted from seconds (50 feet distance) to ms.
‡Converted from seconds (10 m distance) to ms.
§Converted from feet to metres.
¶Exercise versus controls.
**Exercise+vitamins versus vitamins.
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The data from the included records were extracted by
one researcher, which might affect the objectivity of the
process, even if the data extracted were presented to all
the authors for the discussion and approved.
When compared to recent systematic reviews on the
topic, we identiﬁed considerably more relevant studies.
The reason for being able to identify more relevant
reports than previous reviews on the topic did was prob-
ably the fact that the search we performed used very few
limits, relying on the manual (though time-consuming)
ﬁne-tuning of initial search results. Our results are in line
with a recent review by Brienesse et al5 which reported
lack of evidence on the effectiveness of PRT. We ended
up, however, with a more robust conclusion that, based
on several small-sample good-quality RCTs, there is
limited evidence on PRT being no more effective in
Parkinson’s disease than other physical training schemes.
In contrast to our ﬁnding, a review by Lima et al6 sug-
gested that “progressive resistance training should be
implemented in Parkinson’s disease rehabilitation” and a
review by David et al7 concluded that “…there is a strong
rationale for the use of PRE [progressive resistance exer-
cise] as an adjunct treatment in PD [Parkinson’s disease]
…” Such strong recommendations cannot be supported
by our results. Since there is no evidence on the superior-
ity or better safeness of one speciﬁc training scheme over
another in patients with PD, rehabilitation providers may
include or avoid PRT depending on the settled practice
and costs of a particular rehabilitation programme.
In our review, the risk of bias was considered low in 9
of 12 studies. Problems, however, arise from other than
methodological issues covered by the scale we used. It is
likely that the included studies had insufﬁcient statistical
power, undetermined clinical signiﬁcance and mostly
insufﬁciently described treatment in control groups.
They also differed in the degree of disease severity.
Implemented schemes of PRT varied from weightlifting
to boxing exercises. Even if a study was methodologically
well planned and executed, the level of statistical signiﬁ-
cance is rarely achieved in small samples. Only very
large treatment effect sizes could be detected in trials
with 20 or less participants. Additionally, statistically sig-
niﬁcant results, if observed, may not exceed the level of
clinical signiﬁcance, and this should also be taken into
account when making clinical recommendations. For
example, our meta-analyses on fast and comfortable
walking speed and maximal oxygen consumption
showed statistical but not clinical signiﬁcance of pooled
effect sizes. The statistically signiﬁcant pooled effect size
observed in meta-analysis on the 6 min walk test fell
below the level of minimal detectable change for this
test. Unexpectedly, none of the trials followed the effects
of PRT for more than 1 month after the end of a super-
vised training programme. It has been reported previ-
ously that the beneﬁcial effects of training may persist
for several months after the cessation of training.27
The most common source of potential systematic bias
in the selected studies was the lack of blinding of
participants and personnel. This source of bias is hardly
avoidable when physical therapy is involved as the
involvement is based on the close participation of the
patient and the therapist in the entire chain of plan-
ning, performing and assessing the intervention. While
it is barely preventable, it could be statistically con-
trolled, for example, by using repeated measures of
expectancy and beliefs about the demands of the
research throughout the trial.28
The search was a year old at the time of accepting this
review for publication. Thus, the additional verifying
search was conducted on Pubmed seeking relevant
papers published between April 2014 and October 2015
and using the same clauses as did previous search. Only
one potentially relevant trial was identiﬁed. That RCT by
Prodoehl et al29 compared the effects of progressive
resistance exercises and a modiﬁed Fitness Counts
program on the physical function of people with moder-
ate PD. That study used the subset of data used previ-
ously in the paper by Corcos et al included in our
analysis. The main outcome used by Prodoehl et al
included a Modiﬁed Physical Performance Test, ﬁve
times sit to stand test, Functional Reach Test, Timed Up
and Go, Berg Balance Scale, 6 min walk test and 50 feet
walking speed. In a 2-year follow-up, both groups
showed improvements across all studied outcome mea-
sures, except for the 6 min walk test without signiﬁcant
differences between treatment methods. It is reasonable
to assume that the ﬁndings of that trial would not affect
our main results.
To make deﬁnite clinical recommendations possible,
further research should focus on randomised trials on
larger sample sizes and with sufﬁcient follow-up periods
after the end of the intervention. The safety of PRT in a
target population should also be evaluated in compari-
son with other types of physical training. Further studies
may also reveal the effects of resistance training on such
important outcome measures as quality of life, activities
of daily living, cost-effectiveness, and muscle strength,
which are left out of the scope of this review.
Conclusions
Even if physical training is important for health and
functioning, there is so far no evidence on the superior-
ity of progressive resistance training compared with
other treatments to support the use of this technique in
rehabilitation of idiopathic Parkinson’s disease. There is
limited evidence on progressive resistance training being
ineffective in Parkinson’s disease compared with other
physical training schemes.
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